<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03245372</url>
  </required_header>
  <id_info>
    <org_study_id>2017/118</org_study_id>
    <nct_id>NCT03245372</nct_id>
  </id_info>
  <brief_title>Goal Directed Therapy Versus Standard Care in Lung Resection Surgery (GDT-thorax Study).</brief_title>
  <acronym>GDT-thorax</acronym>
  <official_title>Goal Directed Therapy Versus Standard Care in Lung Resection Surgery, a Randomized, Controlled Trial (GDT-thorax Study).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to quantify and compare the hemodynamic control of cardiac
      index in patients who receive either goal-directed therapy or standard hemodynamic management
      in lung resection surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that the percentage of the intraoperative time in which the
      cardiac index is equal or superior to 2.2 l/min/m2 is higher in goal directed therapy
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 10, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of the intraoperative time in which the cardiac index is equal or superior to 2.2 l/min/m2 (%)</measure>
    <time_frame>During the total duration of the surgery</time_frame>
    <description>To compare the degree of hemodynamic control of cardiac index in both groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygenation and tissue perfusion markers</measure>
    <time_frame>Within 24 hours after lung surgery</time_frame>
    <description>To compare lactate, SvcO2 (central venous oxygen saturation) and PaO2/FiO2 ratio (ratio of arterial oxygen partial pressure to fractional inspired oxygen) in the first 24 hours in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluid balance</measure>
    <time_frame>After 24 hours of finalization of lung surgery</time_frame>
    <description>To compare fluid balance (differences between the amount of water taken into the body and the amount excreted or lost) in the first 24 hours in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observation of acute kidney injury (AKI)</measure>
    <time_frame>After 72 hours of finalization of lung surgery</time_frame>
    <description>To compare the incidence of AKI in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observation of acute respiratory distress syndrome (ARDS)</measure>
    <time_frame>Within 30 days after lung surgery</time_frame>
    <description>To compare the incidence of ARDS in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>Within 30 days after lung surgery</time_frame>
    <description>To compare hospital stay in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Within 30 days after lung surgery</time_frame>
    <description>To compare the mortality rate in both groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Goal Directed Therapy</condition>
  <condition>Fluid Therapy</condition>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Basic intraoperative hemodynamic objectives</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Goal directed therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Target value is a cardiac index equal or superior to 2.2 l/min/m2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <description>Heart rate 60-100 beats per minute, mean arterial pressure 65 mm Hg, serum lactate 2 mmol/L, oxygen saturation 95 % (90 % during one lung ventilation).</description>
    <arm_group_label>Standard care</arm_group_label>
    <other_name>Conventional fluid and hemodynamic management</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Goal directed therapy</intervention_name>
    <description>The hemodynamic algorithm will be based on systolic volume index and fluid challenges. FloTrac sensor (this sensor connects to any existing arterial catheter and provides advanced hemodynamic parameters through pulse contour analysis) and EV1000 clinical platform (clinical platform from Edwards Lifesciences that provides advanced hemodynamic monitoring) will be used to calculate cardiac index and systolic volume index.</description>
    <arm_group_label>Goal directed therapy</arm_group_label>
    <other_name>Goal directed fluid and hemodynamic management</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults patients ( 18 years old)

          -  Written informed consent

          -  Elective lung resection surgery (open or thoracoscopic lung lobectomy)

        Exclusion Criteria:

          -  Severe obesity

          -  Moderate to severe aortic insufficiency

          -  Renal failure requiring hemodialysis

          -  Left ventricle ejection fraction less than 35 %

          -  Urgent surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuel Bertomeu, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Andaluz Health Service</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ALEJANDRO DOMÍNGUEZ-BLANCO, MD</last_name>
    <phone>00955012144</phone>
    <email>aledguez@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clara Rosso-Fernández, MD-PhD</last_name>
    <phone>00955012144</phone>
    <email>claram.rosso.sspa@juntadeandalucia.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University hospital Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alejandro Dominguez-Blanco, MD</last_name>
      <phone>00349955012144</phone>
      <email>aledguez@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Clara Rosso-Fernández, MD-PhD</last_name>
      <phone>00349955012144</phone>
      <email>claram.rosso.sspa@juntadeandalucia.es</email>
    </contact_backup>
    <investigator>
      <last_name>Alejandro Dominguez-Blanco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2017</study_first_submitted>
  <study_first_submitted_qc>August 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2017</study_first_posted>
  <last_update_submitted>November 13, 2017</last_update_submitted>
  <last_update_submitted_qc>November 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiac output</keyword>
  <keyword>perioperative care</keyword>
  <keyword>postoperative complications</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Yes. Anonymized data for individual patient data is planned to be shared with all participants within 6 months of data completion</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

